Advanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique
- 7 March 2016
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 30 (3) , 247-261
Abstract
This study aims to investigate the preclinical performance and mechanism of a novel strategy of aFGF-loaded heparin-modified microbubbles (aFGF-HMB) combined with ultrasound-targeted microbubble destruction (UTMD) technique for diabetic cardiomyopathy (DCM) prevention. Type 1 diabetic rats were induced by streptozotocin. Twelve weeks after intervention, indexes from transthoracic echocardiography and cardiac catheterization showed that the left ventricular function in the aFGF-HMB/UTMD group was significantly improved compared with diabetes control (DM). From Picrosirius Red staining and TUNEL staining, the aFGF-HMB/UTMD group showed significant difference from the other groups. The cardiac collagen volume fraction (CVF) and myocardial cell apoptosis index (AI) in aFGF-HMB/UTMD group decreased to 7.2 % and 7.11 % respectively, compared with the DM group (CVF = 24.5 % and AI =20.3 % respectively). The results of myocardial microvascular density (MCD) also proved the strongest inhibition of aFGF-HMB/UTMD group on DCM progress. CD31 staining of aFGF-HMB/UTMD group reached 22 n/hrp, much higher than that of DM group (9 n/hrp). These results confirmed that the abnormalities including left ventricular dysfunction, myocardial fibrosis, cardiomyocytes apoptosis and microvascular rarefaction could be suppressed by twice weekly aFGF treatments for 12 consecutive weeks (free aFGF or aFGF-HMB+/−UTMD), with the strongest improvements observed in the aFGF-HMB/UTMD group (P < 0.05 vs free aFGF or aFGF-HMB). Western blot analyses of heart tissue further revealed the highest aFGF, anti-apoptosis protein (Bcl-2), VEGF-C, pAkt, pFoxo-3a levels and strongest reduction in pro-apoptosis proteins (Bax) level in aFGF-HMB/UTMD group. Overall, aFGF-HMB combined with UTMD technique might be developed as an effective strategy to prevent DCM in future clinical therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81360195, 81571392 and 81272160, 81301982)
This publication has 42 references indexed in Scilit:
- Regulation of interplay between autophagy and apoptosis in the diabetic heartAutophagy, 2013
- Angiogenesis in the Infarcted MyocardiumAntioxidants & Redox Signaling, 2013
- Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblastsLife Sciences, 2013
- Macrovascular complication phenotypes in type 2 diabetic patientsCardiovascular Diabetology, 2013
- Left Ventricular Radial Systolic Dysfunction in Diabetic Patients Assessed by Myocardial Acceleration Derived From Velocity Vector ImagingJournal of Ultrasound in Medicine, 2012
- Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrixCanadian Journal of Physiology and Pharmacology, 2012
- Pre-Diabetes, Metabolic Syndrome, and Cardiovascular RiskJACC, 2012
- Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathyBiochemical and Biophysical Research Communications, 2010
- Principles and Therapeutic Implications of Angiogenesis, Vasculogenesis and Arteriogenesis2006
- Isolation, characterization, and localization of heparin-binding growth factors in the heart.Journal of Clinical Investigation, 1990